Posted in | News | Nanobusiness

Ascensus Specialties Acquires Strem Chemicals

Bellevue, WA, April 7, 2021 – Wind Point Partners (“Wind Point”) and Ascensus Specialties LLC (“Ascensus”) today announced that Ascensus has completed the acquisition of Strem Chemicals, Inc. (“Strem” or the “Company”). Strem is a global leader in high-purity, research-grade catalysts, ligands, organometallics, metal carbonyls and CVD/ALD precursors.

Based in Newburyport, Massachusetts, Strem sells and manufactures specialty chemicals for the most demanding, high-purity end markets of life sciences, microelectronics and other specialties markets. Founded in 1964 by Michael Strem, the Company’s products serve as critical components for manufacturers, researchers and academics. In addition, Strem provides custom synthesis and cGMP manufacturing services for high-potency APIs (active pharmaceutical ingredients).

Headquartered in Bellevue, Washington, Ascensus is the world leader in borohydride, borane, and specialty alcoholates production. Wind Point built Ascensus through the acquisitions of former Dow Chemical and BASF specialty chemicals businesses. Ascensus’ specialty chemicals are essential reagents for life sciences, microelectronics and other specialties customers across North America, Europe and Asia.

Mike Huff, CEO of Ascensus, stated, “We are extremely excited to have Strem join the Ascensus family. Strem has a world-class team and a renowned reputation that has been methodically fostered for over half a century under the leadership of Michael Strem and Ephraim Honig. We will look to further support the team’s highly technical R&D culture, differentiated product offering and value-added customer relationships. Together, Ascensus and Strem will be a global specialty chemicals leader serving the demanding, high-growth life sciences and specialties markets.”

Alex Washington, Wind Point Managing Director, added, “Strem represents an excellent addition to the Ascensus platform. The combined business will have capabilities to offer solutions ranging from lab to large scale commercial production. Strem’s industry-leading technical competency is a meaningful addition to Ascensus’ existing capabilities, and Ascensus looks forward to working with Ephraim and the Strem team to amplify new product and application development efforts.”

Ephraim S. Honig, former CEO of Strem, will be joining the Ascensus leadership team as Chief Science and Innovation Officer and will oversee the combined businesses’ Research and Development function. Mr. Honig noted, “We are excited to become part of the Ascensus family and begin the next chapter for our employees, customers and partners. Ascensus and Strem have highly complementary chemistry capabilities and end market applications. We look forward to accelerating our investment in R&D capabilities to drive innovation and new chemistries on behalf of our customers.”

Michael Strem, Founder & President of Strem Chemicals, commented, “We thoughtfully chose Ascensus as the partner for the next phase of Strem’s growth. Our employees’ interests and well-being have been my top priority, and the strong cultural fit will provide opportunities for our team. The additional resources and global reach of Ascensus will deliver Strem’s strong capabilities to an even broader audience of customers."

Reed Smith LLP served as legal counsel to Wind Point and Ascensus, and KPMG LLP provided advisory services in connection with the transaction. Honigman LLP served as legal counsel and Grace Matthews, Inc. served as financial advisor to Strem.

About Ascensus Specialties

Headquartered in Bellevue, Washington, Ascensus Specialties LLC is the global leader in borohydride, borane and specialty alcoholate reagents. Ascensus chemistries improve the way its clients create their products by making what they do easier, more efficient, safer and more selective. From world-class production plants in Elma, Washington, and Evans City, Pennsylvania, Ascensus has a global reach that ensures that clients can consistently manufacture their products to the highest standards.

Additional information about Ascensus is available at

About Strem Chemicals

Strem Chemicals, Inc., established in 1964, is a manufacturer and marketer of specialty chemicals of high purity. Strem’s key offerings include catalysts, ligands, organometallics, metal carbonyls and CVD/ALD precursors. The Company’s products are used for research and development and commercial scale applications, particularly within life sciences, microelectronics, and other specialties end markets. Strem also provides custom synthesis (including high pressure synthesis) and cGMP manufacturing services.

Additional information about Strem Chemicals is available at

About Wind Point Partners

Wind Point Partners is a Chicago-based private equity investment firm with approximately $3.5 billion in assets under management. Wind Point focuses on partnering with top caliber management teams to acquire well-positioned middle market businesses where it can establish a clear path to value creation. The firm targets investments in the consumer products, industrial products and business services sectors. Wind Point is currently investing out of Wind Point Partners IX, a $1.5 billion fund that was initiated in 2019.

Additional information about Wind Point is available at



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Strem Chemicals. (2024, February 13). Ascensus Specialties Acquires Strem Chemicals. AZoNano. Retrieved on April 19, 2024 from

  • MLA

    Strem Chemicals. "Ascensus Specialties Acquires Strem Chemicals". AZoNano. 19 April 2024. <>.

  • Chicago

    Strem Chemicals. "Ascensus Specialties Acquires Strem Chemicals". AZoNano. (accessed April 19, 2024).

  • Harvard

    Strem Chemicals. 2024. Ascensus Specialties Acquires Strem Chemicals. AZoNano, viewed 19 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.